Clinical epidemiology of invasive cutaneous malignant melanoma in the Austrian province Styria in the years 2001-2003 and its relationship with local geographical, meteorological and economic data

Dermatology

Volumn 214, Issue 3, 2007, Pages 246-252

  Richtig, Erika ^a   Berghold, Andrea ^a   Schwantzer, Gerold ^a   Ott, Arthur ^a   Wölfelmaier, Friedrich ^c   Karner, Beatrix ^b   Ludwig, Ralf ^a   Denk, Helmut ^a   Stering, Reinhold ^d   Leitner, Gerhard ^d   Lax, Sigurd ^b   Okcu, Murat ^b   Gerger, Armin ^a   Kerl, Helmut ^a   Smolle, Josef ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b General Hospital Graz West   (Austria)

^c ZAMG Zentralanstalt fuer Meteorologie und Geodynamik   (Austria)

^d General Hospital of Leoben   (Austria)

Author keywords

Intermittent sun exposure; Melanoma epidemiology; Melanoma incidence

Indexed keywords

ADOLESCENT; AGED; ALTITUDE; ARTICLE; AUSTRIA; CANCER INCIDENCE; CANCER INVASION; CONFIDENCE INTERVAL; CONTROLLED STUDY; EMPLOYEE; ENVIRONMENTAL FACTOR; FEMALE; GEOGRAPHY; HEALTH ECONOMICS; HUMAN; INCOME; LIFESPAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MELANOMA; METEOROLOGY; PATIENT INFORMATION; PRIORITY JOURNAL; RISK ASSESSMENT; SUN; TIME;

ALTITUDE; AUSTRIA; FEMALE; HUMANS; INCOME; MALE; MELANOMA; METEOROLOGICAL FACTORS; MIDDLE AGED; SKIN NEOPLASMS; SOCIOECONOMIC FACTORS;

EID: 33947399812     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099590     Document Type: Article

References (34)

1. Armstrong B: Epidemiology of cutaneous melanoma and current trends; in Thompson JF, Morton DL, Kroon BBR (eds): Textbook of Melanoma. London, Dunitz, 2004, pp 65-80.
2. Hersey P, Morton DL, Eggermont AMM: Adjuvant immunotherapy for high-risk primary melanoma and resected metastatic melanoma; in Thompson JF, Morton DL, Kroon BBR (eds): Textbook of Melanoma. London, Dunitz, 2004, pp 573-585.
3. Khayat D, Meric JB, Rixe O: Systemic chemotherapy and biochemotherapy for nonresected and metastatic melanoma; in Thompson JF, Morton DL, Kroon BBR (eds): Textbook of Melanoma. London, Dunitz, 2004, pp 586-601.
4. Nashan D, Haufs MG, Kleinheinz J, Al-Dandashi C, Bruckner-Tuderman L: Prolonged untreated and treated course of a malignant melanoma. Dermatology 2006;212:93-95.
5. Boyle P, Dore JF, Autier P, Ringborg U: Cancer of the skin: a forgotten problem in Europe. Ann Oncol 2004;15:5-6.
6. Katalinic A, Kunze U, Schäfer T: Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidermiology of skin cancer). Br J Dermatol 2003;149:1200-1206.
7. De Vries E, Bray FI, Coebergh JW, Parkin DM; for the European Network of Cancer Registries: Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia. Int J Cancer 2003;107:119-126.
8. Diepgen TL, Mahler V: The epidemiology of skin cancer. Br J Dermatol 2002;146(suppl 61):1-6.
9. Garbe C, McLeod GR, Buettner PG: Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 2000;89:1269-1278.
10. Volkenandt M, Schmidt M, Konz B, Gummer M, Hein R, Plewig G, Hölzel D: Klinischepidemiologische Daten von Patienten mit malignen Melanomen aus dem Bereich des Tumorzentrums München von 1977 bis 1997. Hautarzt 1999;50:470-478.
11. Stang A, Stabenow R, Eisinger B, Jöckel KH: Site- and gender-specific time trend analyses of the incidence of skin melanomas in the former German Democratic Republic (GDR) including 19351 cases. Eur J Cancer 2003;39:1610-1618.
12. De Vries E, Schouten LJ, Visser O, Eggermont AMM, Coebergh JWW, for the Working Group of Regional Cancer Registries: Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient? Eur J Cancer 2003;39:1439-1446.
13. Newnham A, Moller H: Trends in the incidence of cutaneous malignant melanomas in the south east of England, 1960-1998. J Public Health Med 2002;24:268-275.
14. Balzi D, Carli P, Giannotti B, Paci E, Buiatti E: Cutaneous melanoma in the Florentine area, Italy: incidence survival and mortality between 1985 and 1994. Eur J Cancer Prev 2003;12:43-48.
15. Quatresooz P, Uhoda I, Fumal I, Piérard-Franchimont C, Piérard G: Revisiting the gender-linked melanoma burden. Dermatology 2006;209:197-201.
16. Dore JF, Boniol M: Environment influences on cutaneous melanoma; in Thompson JF, Morton DL, Kroon BBR (eds): Textbook of Melanoma. London, Dunitz, 2004, pp 43-55.
17. Tucker MA, Goldstein AM: Melanoma etiology: where are we? Oncogene 2003;22:3042-3052.
18. Amsel J, Waterbor JW, Oler J, Rosenwaike I, Marshall K: Relationship of site-specific cancer mortality rates to altitude. Carcinogenesis 1982;5:461-465.
19. Halliday GM: Skin immunity and melanoma development; in Thompson JF, Morton DL, Kroon BBR (eds): Textbook of Melanoma. London, Dunitz, 2004, pp 25-42.
20. Kefford RF, Mann GJ, Bishop JN: Genetic predisposition to melanoma; in Thompson JF, Morton DL, Kroon BBR (eds): Textbook of Melanoma. London, Dunitz, 2004, pp 56-64.
21. Hallberg Ö: A theory and model to explain the skin melanoma epidemic. Melanoma Res 2006;16:115-118.
22. Garbe C, Cerroni L, Kerl H: Melanozytäre Nävi und malignes Melanom; in Kerl H, Garbe C, Cerroni L, Wolff HH (eds): Histopathologie der Haut. Berlin, Springer, 2003, pp 593-649.
23. Schaffer JV, Darrell RS, Kopf AW, Bolognia JL: Cutaneous melanoma - past, present, and future. J Am Acad Dermatol 2004;51:S65-S69.
24. Rieger E, Soyer HP, Kofler R, Hödl S, Smolle J, Richtig E, Kerl H: Klinisch-epidemiologische Daten des malignen Melanoms anhand von 1368 Patienten der Grazer Universitäts-Hautklinik (1970-1989). Wien Klin Wochenschr 1991;103:612-616.
25. Garbe C, Blum A: Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol 2001;14:280-290.
26. www.statistik-austria.at/fachbereich_03/krebs/haut1.shtml
27. www.statistik-austria.at/fachbereich_03/krebs/haut3.shtml
28. www.statistik-austria.at/fachbereich_03/krebs/haut4.shtml
29. Jones WO, Harman CR, Ng AK, Shaw JH: Incidence of malignant melanoma in Auckland, New Zealand: highest rates in the world. World J Surg 1999;23:732-735.
30. Kölmel KF, Lippold A, Kulle B, Veltmaat S, Stoltenberg M, Seebacher C: Zur Sterblichkeit am kutanen invasiven malignen Melanom. Hautarzt 2001;52:211-218.
31. Pehamberger H, Binder M, Knollmayer S, Wolff K: Immediate effects of a public education campaign on prognostic features of melanoma. J Am Acad Dermatol 1993;29:106-109.
32. Pehamberger H: '10 Jahre Sonne ohne Reue'; in Wayand W, Pehamberger H, (eds): Onkologisch. Wien, Österreichische Krebshilfe-Krebsgesellschaft, 1998, p 31.
33. Hofmann-Wellenhof R, Soyer HP, Richtig E, Wolf IH, Smolle J, Scherer C, Kerl H: Should dermatologists go public? A skin cancer screening campaign at recreation centers. Arch Dermatol 2000;136:938-940.
34. Kittler H, Binder M, Wolff K, Pehamberger H: A ten-year analysis of demographic trends for cutaneous melanoma: analysis of 2501 cases treated at the University Departmentof Dermatology in Vienna (1990-1999). Wien Klin Wochenschr 2001;113:321-327.